Monte Rosa Therapeutics, Inc. GLUE Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s capital investments accrued but not yet paid?
- Monte Rosa Therapeutics, Inc. (GLUE) reported capital investments accrued but not yet paid of $2.74M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s capital investments accrued but not yet paid increased by 800.0% year-over-year, from $304K to $2.74M.